Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Lerna Bio unveils its first-in-class solution to combat liver failure 2023-11-06 22:00
I-Mab Announces Participation at Jefferies and Piper Conferences in November 2023-11-06 21:00
Phase I Study Results for Qilu Pharmaceutical's Iparomlimab (QL1604) Now Published 2023-11-06 18:54
'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum 2023-11-06 17:07
Gannex Published Phase I Data of ASC42, a Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D 2023-11-06 12:20
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval 2023-11-06 09:11
Innovent Presents Clinical Data of Two Ophthalmic Bispecific Antibodies IBI302 (anti-VEGF/complement) and IBI324 (anti-VEGF-A/Ang-2) at American Academy of Ophthalmology (AAO) Annual Meeting 2023 2023-11-06 08:00
Sanyou Bio Congratulates KangaBio on their IND Approval for Next-Generation IL-12 Prodrug Cancer Immunotherapy 2023-11-05 08:00
Verismo Therapeutics Announces Upcoming Presentation at SITC 2023 2023-11-03 21:00
The 2nd Boao International Conference on Real World Studies of Medical Products Held in Hainan 2023-11-03 12:10
ASH 2023 | Ascentage Pharma to Present Results from Three Clinical Studies of Bcl-2 Inhibitor Lisaftoclax (APG-2575), Including the First Data in AML and MM 2023-11-03 09:15
ASH 2023 | For the Sixth Consecutive Year, Results from Multiple Clinical Studies of Olverembatinib Have Been Selected for Presentations, Including Two Oral Reports, at the 2023 ASH Annual Meeting 2023-11-03 09:10
PolyActiva reports promising clinical trial results for its 6-month sustained drug delivery, biodegradable ocular implant in glaucoma patients. 2023-11-03 05:15
Lion TCR clinched the prestigious T-Up Excellence Awards in Singapore 2023-11-02 20:41
Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN) 2023-11-02 20:00
Ivonescimab's Novel Mechanism of Action Highlighting Cooperative Binding to be Featured in Poster Presentation at SITC 2023 2023-11-02 20:00
European Medicines Agency validates Pierre Fabre Laboratories' marketing authorisation application for combination BRAFTOVI® (encorafenib) and MEKTOVI® (binimetinib) for patients with BRAFV600-mutant advanced non-small cell lung cancer (NSCLC) 2023-11-02 18:52
Cambrex Announces Sale of Drug Product Business Unit 2023-11-02 18:00
Chipscreen's New Drug Candidate CS32582 Capsules Approved for Clinical Treatment of Psoriasis 2023-11-02 15:58
Xinhua Silk Road: 54th Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's Jiangxi 2023-11-02 14:21
1 33 34 35 36 37 377